NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,077 filers reported holding NOVARTIS A G in Q3 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $789,618 | +0.5% | 7,752 | -0.5% | 0.59% | +3.2% |
Q2 2023 | $785,887 | +41.1% | 7,788 | +28.7% | 0.57% | +32.4% |
Q1 2023 | $556,876 | +15.4% | 6,053 | +13.8% | 0.43% | +0.7% |
Q4 2022 | $482,359 | +21.2% | 5,317 | +1.5% | 0.43% | +11.5% |
Q3 2022 | $398,000 | -16.2% | 5,236 | -6.8% | 0.38% | -9.7% |
Q2 2022 | $475,000 | -6.1% | 5,620 | -2.5% | 0.42% | +12.5% |
Q1 2022 | $506,000 | -4.5% | 5,762 | -5.1% | 0.38% | +3.3% |
Q4 2021 | $530,000 | +1.9% | 6,069 | -4.5% | 0.36% | -8.3% |
Q3 2021 | $520,000 | +1.0% | 6,353 | +12.6% | 0.40% | -1.0% |
Q2 2021 | $515,000 | +1.6% | 5,641 | -5.2% | 0.40% | -5.9% |
Q1 2021 | $507,000 | -13.3% | 5,953 | -4.2% | 0.43% | -15.3% |
Q4 2020 | $585,000 | +5.2% | 6,212 | -3.1% | 0.50% | -0.4% |
Q3 2020 | $556,000 | +1.1% | 6,414 | +1.7% | 0.50% | -5.4% |
Q2 2020 | $550,000 | +15.3% | 6,306 | +8.6% | 0.53% | -9.2% |
Q1 2020 | $477,000 | -14.2% | 5,804 | -1.4% | 0.59% | +4.8% |
Q4 2019 | $556,000 | – | 5,884 | – | 0.56% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |